Related Experiment Video
Updated: Feb 25, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Necrotizing pneumonia: an emerging problem in children?
I Brent Masters1, Alan F Isles1, Keith Grimwood2,3
1Department of Respiratory and Sleep Medicine, Lady Cilento Children's Hospital, South Brisbane, QLD Australia.
Necrotizing pneumonia (NP) in children is a severe lung condition characterized by parenchymal destruction and cavities. While often treatable with prolonged antibiotics and supportive care, further research is needed due to limited data.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Radiology
Background:
- Necrotizing pneumonia (NP) is a severe, uncommon complication of pneumonia in children.
- Characterized by lung parenchymal destruction, leading to thin-walled cavities, often with empyema and bronchopleural fistulae.
Purpose of the Study:
- To review the current understanding of necrotizing pneumonia in children.
- To highlight diagnostic methods, common pathogens, and therapeutic approaches.
- To emphasize the need for further research into pathogenesis, treatment, and prevention.
Main Methods:
- Review of existing literature on pediatric necrotizing pneumonia.
- Analysis of diagnostic imaging, particularly contrast-enhanced CT scans.
- Discussion of microbiological diagnostic methods, including blood and pleural fluid cultures.
- Summary of current therapeutic strategies, including antibiotics and supportive care.
Main Results:
- Increasing incidence of NP attributed to heightened awareness, advanced imaging (CT scans), evolving pathogens, and antibiotic practices.
- Commonly identified pathogens include pneumococci and Staphylococcus aureus.
- Diagnosis relies on imaging showing parenchymal destruction and cavities; microbiologic diagnosis achieved in up to 50% of cases.
- Despite severity, mortality is low, with good recovery within 5-6 months with appropriate management.
Conclusions:
- Current understanding of NP is based on limited case reports and small, retrospective, single-center studies.
- Lack of randomized-controlled trial data hinders definitive treatment guidelines.
- Findings may not be generalizable due to variations in pathogen behavior, immunization, and prescribing practices across regions.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis I: Introduction

